Human Regulatory T Cells of G-CSF Mobilized Allogeneic Stem Cell Donors Qualify for Clinical Application

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Ukena, Sya N ^a   Velaga, Sarvari ^a   Goudeva, Lilia ^a   Ivanyi, Philipp ^a   Olek, Sven ^b   Falk, Christine S ^a   Ganser, Arnold ^a   Franzke, Anke ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b EPIONTIS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR;

ADULT; ALLOGENEIC STEM CELL DONOR; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DONOR; EFFECTOR CELL; EPIGENETICS; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; MALE; REGULATORY T LYMPHOCYTE; STEM CELL EXPANSION; STEM CELL MOBILIZATION; T LYMPHOCYTE SUBPOPULATION; TRANSIENT EXPRESSION;

ADULT; CELL COUNT; CELL MOVEMENT; CELL PROLIFERATION; CLINICAL TRIALS AS TOPIC; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84871254519     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051644     Document Type: Article

References (36)

1. Tang Q, Bluestone JA, Kang SM, (2012) CD4(+)Foxp3(+) regulatory T cell therapy in transplantation. J Mol Cell Biol 4: 11-21.
2. Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, et al. (2003) CD4(+)CD25(+) regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nature Medicine 9: 1144-1150.
3. Nguyen VH, Shashidhar S, Chang DS, Ho L, Kambham N, et al. (2008) The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood 111: 945-953.
4. Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, et al. (2011) Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117: 1061-1070.
5. di Ianni M, Falzetti F, Carotti A, Terenzi A, Castellino F, et al. (2011) Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117: 3921-3928.
6. Anderlini P, Champlin RE, (2008) Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges. Blood 111: 1767-1772.
7. Franzke A, Piao WJ, Lauber J, Gatzlaff P, Konecke C, et al. (2003) G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood 102: 734-739.
8. Boneberg EM, Hareng L, Gantner F, Wendel A, Hartung T, (2000) Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma. Blood 95: 270-276.
9. Hartung T, Docke WD, Gantner F, Krieger G, Sauer A, et al. (1995) Effect of Granulocyte-Colony-Stimulating Factor Treatment on Ex-Vivo Blood Cytokine Response in Human Volunteers. Blood 85: 2482-2489.
10. Arpinati M, Green CL, Heimfeld S, Heuser JE, Anasetti C, (2000) Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95: 2484-2490.
11. Klangsinsirikul P, Russell NH, (2002) Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2CD4 phenotype and a predominance of type 2 dendritic cells. Experimental Hematology 30: 495-501.
12. Pan LY, Delmonte J, Jalonen CK, Ferrara JLM, (1995) Pretreatment of Donor Mice with Granulocyte-Colony-Stimulating Factor Polarizes Donor T-Lymphocytes Toward Type-2 Cytokine Production and Reduces Severity of Experimental Graft-Versus-Host Disease. Blood 86: 4422-4429.
13. Zeng D, Jones S, Strober S, (1997) G-CSF reduces the capacity of blood mononuclear cells to induce GVHD: Impact on blood progenitor cell transplantation. Journal of Allergy and Clinical Immunology 99: 1900.
14. Mielcarek M, Graf L, Johnson G, Torok-Storb B, (1998) Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: A mechanism for monocyte-mediated suppression of T-cell proliferation. Blood 92: 215-222.
15. Rutella S, Bonanno G, Pierelli L, Mariotti A, Capoluongo E, et al. (2004) Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha. European Journal of Immunology 34: 1291-1302.
16. Mielcarek M, Martin PJ, TorokStorb B, (1997) Suppression of alloantigen-induced T-cell proliferation by CD14(+) cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 89: 1629-1634.
17. Rutella S, Pierelli L, Bonanno G, Sica S, Ameglio F, et al. (2002) Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood 100: 2562-2571.
18. Wieczorek G, Asemissen A, Model F, Turbachova I, Floess S, et al. (2009) Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res 69: 599-608.
19. Miyao T, Floess S, Setoguchi R, Luche H, Fehling HJ, et al. (2012) Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 36: 262-275.
20. Franzke A, (2006) The role of G-CSF in adaptive immunity. Cytokine Growth Factor Rev 17: 235-244.
21. Fujisaki J, Wu J, Carlson AL, Silberstein L, Putheti P, et al. (2011) In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 474: 216-219.
22. Semerad CL, Liu F, Gregory AD, Stumpf K, Link DC, (2002) G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity 17: 413-423.
23. Semerad CL, Christopher MJ, Liu F, Short B, Simmons PJ, et al. (2005) G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106: 3020-3027.
24. Kean LS, Sen S, Onabajo O, Singh K, Robertson J, et al. (2011) Significant mobilization of both conventional and regulatory T cells with AMD3100. Blood 118: 6580-3090.
25. Zou LH, Barnett B, Safah H, LaRussa VF, Evdemon-Hogan M, et al. (2004) Bone marrow is a reservoir for CD4(+)CD25(+) regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Research 64: 8451-8455.
26. Kimmig S, Przybylski GK, Schmidt CA, Laurisch K, Mowes B, et al. (2002) Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med 195: 789-794.
27. Shevach EM, (2009) Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645.
28. Ukena SN, Velaga S, Geffers R, Grosse J, Baron U, et al. (2011) Human regulatory T cells in allogeneic stem cell transplantation. Blood 118: e82-e92.
29. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, et al. (2009) Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30: 899-911.
30. Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, et al. (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184: 3433-3441.
31. Hirahara K, Liu L, Clark RA, Yamanaka K, Fuhlbrigge RC, et al. (2006) The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors. J Immunol 177: 4488-4494.
32. Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, et al. (2009) Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 58: 652-662.
33. McClymont SA, Putnam AL, Lee MR, Esensten JH, Liu W, et al. (2011) Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol 186: 3918-3926.
34. Hippen KL, Merkel SC, Schirm DK, Nelson C, Tennis NC, et al. (2011) Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am J Transplant 11: 1148-1157.
35. Hippen KL, Merkel SC, Schirm DK, Sieben CM, Sumstad D, et al. (2011) Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity. Sci Transl Med 3: 83ra41.
36. Hoffmann P, Eder R, Kunz-Schughart LA, Andreesen R, Edinger M, (2004) Large- scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 104: 895-903.